IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies ...
News Medical on MSN13d
Abnormal Immune Cell Function May Lead to Crohn’s Disease
A research team has uncovered abnormal immune cell function mechanisms that may lead to Crohn’s disease. Their discovery ...
News Medical on MSN11d
High-Salt Diet Linked to Depression-like Symptoms
The researchers also identified a type of immune cell called gamma-delta T cells (γδT cells) as an important source of IL-17A ...
Mena FN13d
Researchers Find Mechanisms That May Lead To Inflammatory Bowel Disease
White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta ...
In8bio To Present New Preclinical Data On Novel Gamma-Delta (Γδ) T Cell Engager Platform For Cancer Immunotherapy At AACR Annual Meeting 2025
Poster Title: A novel gamma-delta T cell engager platform for cancer immunotherapy Session Title: Immunology/T Cell Engagers and Novel Antibody-Based Therapies Session Date and Time: Wednesday, April ...